Literature DB >> 6438075

Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.

K Matsumoto, T Yamamoto, R Kamata, H Maeda.   

Abstract

A serratial protease with an apparent molecular weight of 56,000 (56K protease), which had been purified from the culture supernatant of a strain of Serratia marcescens isolated from a corneal lesion of a human eye [Matsumoto, K. et al. (1984) J. Bacteriol. 157, 225-232], greatly enhanced vascular permeability when injected into guinea pig skin. The 56K protease, which requires zinc ion for activity, was found to possess plasma kallikrein-like properties in vitro as judged by (i) preferential amidolysis of carbobenzoxy-Phe-Arg-4-methylcoumaryl-7-amide and Pro-Phe-Arg-4-methylcoumaryl-7-amide, which are known substrates for plasma kallikrein; (ii) release of kinin from high-molecular-weight kininogen; and (iii) prompt activation of Hageman factor followed by generation of kallikrein from plasma prekallikrein. These results suggest that the 56K protease enhances vascular permeability through activation of a Hageman factor-kallikrein-kinin pathway in vivo, and this molecular process appears to be a rational mechanism of enhancement of permeability and serratial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438075     DOI: 10.1093/oxfordjournals.jbchem.a134892

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  36 in total

1.  Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.

Authors:  A Molla; T Akaike; H Maeda
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.

Authors:  H Kaminishi; M Tanaka; T Cho; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture.

Authors:  A Molla; K Matsumoto; I Oyamada; T Katsuki; H Maeda
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections.

Authors:  W König; Y Faltin; J Scheffer; H Schöffler; V Braun
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2.

Authors:  Yutaka Kida; Hiroyoshi Inoue; Takashi Shimizu; Koichi Kuwano
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

6.  Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens.

Authors:  A Molla; T Kagimoto; H Maeda
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

7.  Suppression of polymorphonuclear leucocyte chemotaxis by Pseudomonas aeruginosa elastase in vitro: a study of the mechanisms and the correlation with ring abscess in pseudomonal keratitis.

Authors:  Y Ijiri; K Matsumoto; R Kamata; N Nishino; R Okamura; T Kambara; T Yamamoto
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

8.  Pseudomonas elastase acts as a virulence factor in burned hosts by Hageman factor-dependent activation of the host kinin cascade.

Authors:  I A Holder; A N Neely
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs.

Authors:  R Kamata; T Yamamoto; K Matsumoto; H Maeda
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

10.  CpxR-Dependent Thermoregulation of Serratia marcescens PrtA Metalloprotease Expression and Its Contribution to Bacterial Biofilm Formation.

Authors:  Roberto E Bruna; María Victoria Molino; Martina Lazzaro; Javier F Mariscotti; Eleonora García Véscovi
Journal:  J Bacteriol       Date:  2018-03-26       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.